drugset / Trial / NCT06852092

Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects

NCT06852092

Phase 1 Completed 7 enrolled Haisco Pharmaceutical Group Co., Ltd.
NaSingle-groupOpen-labelHealth-services research

Summary

To evaluate the absorption, metabolism and excretion in healthy Chinese male subjects after a single oral dose of \[14C\]HSK39297

Timeline

Start
2024-09-09
Primary completion
2024-09-27
Completion
2024-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject HSK39297 Unknown Oral